Aleafia Health Completes Breakthrough Medical Cannabis Export to Germany
03 Juni 2021 - 1:00PM
Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or
the “Company”), a global leader in cannabis wellness products and
services, is pleased to announce that dried flower grown at its
Niagara greenhouse facility has been successfully exported to
Germany. Gaining access to Europe’s most mature legal cannabis
market is an important breakthrough for Aleafia Health, with
fulfilment of successive purchase orders to Germany currently
underway.
Germany represents the second major medical cannabis market to
which the Company has successfully completed exports. Import and
export permits have been secured for two additional orders to
Australia, with the shipments expected to occur in June.
“The investments we’ve made in the highest levels of global
regulatory compliance are just now beginning to pay dividends as we
gain access to the largest medical cannabis market in the world.
The shipment itself is an incredibly important breakthrough. More
importantly, it represents an entirely new sales channel that will
deliver consistent, repeatable revenue,” said Aleafia Health CEO
Geoffrey Benic. “With such high barriers to entry, the German
cannabis market opportunity perfectly complements this quarter’s
continued growth in our domestic medical and adult-use
channels.”
The European cannabis market is expected to be worth $4.7
billion by 2025, with Germany alone representing nearly half the
total market size, according to research from Prohibition
Partners.
The first shipment features Aleafia Health’s signature THC
cultivar Sour Kush. While dried flower currently available in
Germany is largely irradiated, the product shipped exceeded
stringent quality standards and did not require irradiation,
offering a significant competitive advantage in product quality.
The export was completed through the EU-GMP certified facility of a
strategic partner.
For Investor & Media Relations:
Nicholas Bergamini, VP Investor
Relations1-833-879-2533IR@AleafiaHealth.comLEARN MORE:
www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a vertically integrated and federally licensed
Canadian cannabis company offering cannabis health and wellness
services and products in Canada and with sales and operations in
Australia and Germany. The Company operates medical clinics,
education centres and production facilities for the production and
sale of cannabis.
Aleafia Health owns four significant licensed cannabis
production facilities, including the first large-scale, legal
outdoor cultivation facility in Canadian history. The Company
produces a diverse portfolio of commercially proven, high-margin
derivative products including oils, capsules, edibles, sublingual
strips, and vapes. Aleafia Health operates the largest national
network of medical cannabis clinics and education centres staffed
by MDs, nurse practitioners and educators and operates
internationally in three continents.
Forward Looking Information
This news release contains forward-looking information within
the meaning of applicable Canadian and United States securities
laws. Often, but not always, forward-looking information can be
identified by the use of words such as “plans”, “expects”,
“estimates”, “intends”, “anticipates”, or “believes” or variations
of such words and phrases or state that certain actions, events or
results “may”, “could”, “would”, “might” or “will” be taken, occur
or be achieved. Forward-looking information involves known and
unknown risks, uncertainties and other factors which may cause the
actual results, performance or achievements of the Company or its
subsidiaries to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information, including
risks contained in the Company’s annual information form filed with
Canadian securities regulators available on the Company’s SEDAR
profile at www.sedar.com. Although the Company believes that the
assumptions and factors used in preparing the forward-looking
information in this news release are reasonable, undue reliance
should not be placed on such information and no assurance can be
given that such events will occur in the disclosed time frames or
at all. The forward-looking information included in this news
release are made as of the date of this news release and the
Company does not undertake any obligation to publicly update such
forward-looking information to reflect new information, subsequent
events or otherwise unless required by applicable securities
legislation.
Aleafia Health (TSX:AH)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Aleafia Health (TSX:AH)
Historical Stock Chart
Von Apr 2023 bis Apr 2024